Stenabolic (SR-9009) is a brand new chemical that has proven in animal studies to boost exercise endurance as well as treat metabolic syndrome. SR-9009 is often referred to as “exercise in a bottle” due to the rapid increase in metabolism that occurs with use. Scientists believe that SR-9009 will be used in the future as a cure for illnesses that severely limit exercise endurance. These instances may include obesity, congestive heart failure, COPD (chronic obstructive pulmonary disease) as well as the deterioration of muscle capacity that is commonly linked with the again process.
Stenabolic (SR-9009) possesses the capabilities of reducing obesity as well as reversing metabolic syndrome. In animal studies, it has shown to increase the metabolic activity of skeletal muscle in mice. Treated mice became lean while developing larger muscles. They also had a 50% increase in running ability, imitating the effect of aerobic exercise. Stenabolic alters the metabolic profile of skeletal muscle in a manner similar to the changes observed in animals that are endurance trained. In simple terms, SR-9009 sends a signal to the muscle to tell it to modify its current metabolism.
During the day, metabolism naturally speeds up and slows down. This means that at times, food is used for energy and at other times, it gets stored as fat. SR-9009 has been shown to improve a dysfunctional metabolic clock, ensuring that food and excess fat are used as energy. It binds to Rev-ErbA, which is a natural transcription factor in our cells that influences lipid and glucose metabolism in the liver, improving inflammatory responses in fat-storing cells. This process allows SR-9009 to positively modulate metabolism, which is associated with increased muscle strength. Furthermore, SR-9009 has been shown to increase exercise capacity (running time and distance).